Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS
Author:
Publisher
Springer Science and Business Media LLC
Subject
Rheumatology
Link
https://link.springer.com/content/pdf/10.1007/s11926-021-01006-w.pdf
Reference87 articles.
1. •• Sammaritano LR, Bermas BL, Chakravarty E, Chambers C, Clowse ME, Lockshin MD, et al. 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Care Res. 2020;72(4):461–88 This guideline presents recommendations regarding contraception, fertility preservation, assisted reproductive technology, pregnancy assessment and management, hormone replacement therapy and medication use before, during and after pregnancy. The recommendations are directed towards patients with any rheumatic disease, but specific recommendations are provided for patients with SLE, APS and anti-Ro and La antibodies where relevant.
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera RH, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
3. Schwartz EB, Manzi S. Risk of unintended pregnancy among women with systemic lupus erythematosus. Arthritis Rheum. 2008;59(6):863–6.
4. Yazdany J, Trupin L, Kaiser R, et al. Contraceptive counseling and use among women with systemic lupus: a gap in health care quality? Arthritis Care Res. 2011;63(3):358–65.
5. Birru Talabi M, Clowse ME, Blalock SJ, Moreland L, Siripong N, Borrero S. Contraception use among reproductive-age women with rheumatic diseases. Arthritis Care Res. 2019;71(8):1132–40.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Contraception for antiphospholipid syndrome and systemic lupus erythematosus (according to the recommendations of the European Alliance of Associations for Rheumatology/American College of Rheumatology, EULAR/ACR);Rheumatology Science and Practice;2024-02-29
2. Do we need more guidance on thrombophilia testing? Challenges and special considerations;Expert Review of Hematology;2024-01-22
3. Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome;Seminars in Thrombosis and Hemostasis;2024-01-16
4. Hormones and thrombosis: the dark side of the moon;BLOOD TRANSFUS-ITALY;2024
5. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children;La Revue de Médecine Interne;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3